Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data

BACKGROUND: To treat acute schizophrenia, a long-acting injectable antipsychotic needs a rapid onset of action and therapeutic profile similar to that of oral agents. The present post-hoc analyses compared results from a randomized, double-blind, placebo-controlled trial of olanzapine long-acting in...

Descripción completa

Detalles Bibliográficos
Autores principales: Detke, Holland C, Zhao, Fangyi, Witte, Michael M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403915/
https://www.ncbi.nlm.nih.gov/pubmed/22646847
http://dx.doi.org/10.1186/1471-244X-12-51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403915/
https://www.ncbi.nlm.nih.gov/pubmed/22646847
http://dx.doi.org/10.1186/1471-244X-12-51

Ejemplares similares